Nuo Therapeutics, Inc.
AURX
$1.63
$0.00460.28%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.24% | 21.93% | 26.73% | 28.68% | 25.20% |
| Total Depreciation and Amortization | 21.23% | -5.14% | -8.46% | -7.23% | 1.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.96% | -75.51% | -83.57% | 2.08% | 2,364.37% |
| Change in Net Operating Assets | 551.72% | 331.55% | 87.74% | -113.05% | -751.74% |
| Cash from Operations | 73.76% | 43.18% | 29.55% | 27.29% | 22.99% |
| Capital Expenditure | -6,275.00% | -20,157.89% | -2,052.78% | -1,213.56% | 56.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6,275.00% | -20,157.89% | -2,052.78% | -1,213.56% | 56.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -66.44% | -12.81% | -12.81% | 152.53% | 459.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -66.44% | -12.81% | -12.81% | 152.53% | 459.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -312.62% | 66.92% | 45.23% | 102.02% | 102.42% |